


Terms & Conditions
Effective Date: October 18, 2026
These Terms & Conditions govern your use of services, communications, and this website provided by Oxytocin, a licensed Substance Use Disorder (SUD) treatment facility and behavioral health provider located in Montana.
1. Services Provided
Oxytocin provides comprehensive behavioral health services, including but not limited to:
-
Substance Use Disorder (SUD) Assessments
-
Mental Health Assessments
-
Intensive Outpatient (Level 2.1) Services
-
Outpatient (Level 1) Services
-
Individual Counseling
-
Group Counseling
-
Co-Occurring Disorder Treatment
-
Moral Reconation Therapy (MRT)
-
DUI/ACT Assessments and Prime for Life Programs
-
Minor in Possession (MIP) Programs
-
Care Management
-
Peer Support Services
-
Prevention and Community Education
We may provide services in person or, when clinically appropriate, through HIPAA-compliant telehealth platforms.
2. Emergency & Crisis Disclaimer
We do not provide 24-hour emergency crisis services or operate a 24/7 crisis hotline. However, we work in conjunction with local authorities and the Crisis Assistance Team to support individuals who may be experiencing a crisis.
If an individual is experiencing an immediate emergency, medical crisis, mental health crisis, or is at risk of harming themselves or others, they should call 911 or go to the nearest emergency department. Staff will assist with appropriate referrals and coordination with crisis services when needed, but our agency is not a substitute for emergency response or 24-hour crisis care.
Text messages, emails, website submissions, and voicemail messages are intended for administrative communication and are not monitored continuously or in real time.
If you are experiencing a medical emergency, psychiatric emergency, or believe you or someone else is in immediate danger:
-
Emergency Assistance: Call 911 and request the crisis team if you are concerned about your immediate safety or someone else's.
-
Non-Emergent Support & Referrals: Call 988 to reach the Suicide and Mental Health Crisis Lifeline for resource referrals or initial de-escalation.
-
Go to the nearest emergency department.
Do not use text messaging, email, or website forms for urgent clinical concerns or emergencies.
3. SMS & Electronic Communications
Oxytocin uses authorized messaging providers to communicate with clients through SMS text messages, MMS messages, voicemail notifications, telephone calls, email, and other electronic communication methods.
Communications are provided according to the client's applicable authorization and selected communication preferences.
Message Types
Communications may include:
-
Appointment confirmations
-
Appointment reminders
-
Scheduling changes or cancellations
-
Billing notifications
-
Care coordination updates
-
Treatment-related administrative communications
-
Requests for required documentation
-
Random drug and alcohol testing notifications
Messaging Systems
Elevate: Provides direct, two-way telephone and text messaging communication between clients and their assigned clinicians for treatment-related questions, appointment scheduling, care coordination, and other clinical needs. Clients may call or text their clinician directly and receive individual responses.
Electronic Health Record (EHR): Oxytocin's EHR system generates and sends appointment reminders and related scheduling notifications based on the client's authorization.
Twilio: Upon campaign approval and activation, Oxytocin's random testing scheduling system will use Twilio to deliver same-day SMS notifications to clients who have separately authorized random testing text notifications.
Consent
Oxytocin obtains consent through the applicable written authorization. Appointment reminders and random testing notifications require separate authorizations.
Providing a mobile telephone number alone does not constitute consent to receive automated SMS messages.
Consent to optional SMS communications is voluntary and is not a condition of receiving treatment.
Oxytocin Clinic does not sell or share mobile telephone numbers, SMS opt-in information, or messaging consent records with third parties or affiliates for marketing or promotional purposes. Information necessary to provide authorized communications may be shared with approved service providers, subject to applicable privacy, confidentiality, and legal requirements.
4. Oxytocin SMS Terms and Conditions
Links:
Terms and Conditions: https://www.oxytocinclinic.com/terms-and-conditions
Privacy Policy: https://www.oxytocinclinic.com/notice-of-privacy-practices
National Do Not Call Registry: https://www.donotcall.gov/
Introduction
At Oxytocin LLC, operating as Oxytocin Clinic, we prioritize protecting our clients' privacy and confidentiality. These SMS Terms and Conditions explain the requirements, responsibilities, and procedures associated with our electronic messaging programs. Oxytocin provides optional, nonmarketing SMS text notifications related to treatment appointments, scheduling, and required random drug and alcohol testing.
SMS communications related to appointment reminders and random drug and alcohol testing notifications are provided ONLY when the client has completed the applicable written authorization form. Consent to receive these SMS notifications is voluntary and is not a condition of receiving treatment.
Oxytocin maintains three separate electronic communication systems, each serving a distinct purpose and operating according to the client's applicable communication preferences and authorization requirements.
-
Elevate: Provides direct, two-way telephone and text messaging communication between clients and their assigned clinicians for treatment-related questions, appointment scheduling, care coordination, and other clinical needs. Clients may call or text their clinician directly and receive individual responses.
-
Electronic Health Record (EHR): Sends authorized appointment reminders and related scheduling notifications directly through the EHR.
-
Twilio: Will provide automated random drug and alcohol testing notifications through Oxytocin's random testing scheduling system once the messaging campaign is approved and activated.
All three programs provide nonmarketing communications and operate according to the client's applicable authorization and communication preferences.
A. Information We Collect
Oxytocin collects and maintains information necessary to provide authorized communications, including:
-
Contact Information: Mobile telephone numbers and other authorized contact information.
-
Message Interaction Data: Message dates, transmission and delivery status when available, and supported response keywords.
-
Consent Records: Signed appointment reminder authorizations, signed random testing SMS authorizations, consent dates, selected communication preferences, and documented changes or revocations.
-
Messaging Records: Information necessary to administer notifications, document communication activities, and prevent messages following an opt-out.
Oxytocin collects and maintains information in accordance with applicable privacy, confidentiality, and recordkeeping requirements.
B. How We Use Your Information
Oxytocin uses authorized contact and messaging information to:
-
Provide Direct Communication Through Elevate: Facilitate direct, two-way telephone calls and text messaging between clients and their assigned clinicians for treatment-related questions, appointment scheduling, care coordination, and other authorized clinical communications.
-
Provide EHR Appointment Reminders: Send appointment reminders and related scheduling notifications through Oxytocin's Electronic Health Record, based on the communication methods the client selects.
-
Provide Twilio Random Testing Notifications: Send same-day SMS notifications when an authorized client is selected for required random drug or alcohol testing.
-
Maintain and update client communication preferences.
-
Document consent, opt-out requests, and applicable messaging activity.
-
Monitor message transmission and delivery when available.
-
Support the administration, security, and reliability of authorized communication systems.
Oxytocin uses SMS information for authorized treatment-related and administrative communications, not promotional or marketing purposes.
C. One-to-One Consent Requirement
Oxytocin obtains and documents client consent for its messaging programs according to the applicable authorization process.
Direct Client Communication through Elevate
Oxytocin Clinic utilizes Elevate as its business telephone and messaging system to facilitate direct, two-way communication between clients and their assigned clinicians.
Through Elevate, clients may call or text their clinician with treatment-related questions, appointment scheduling, care coordination, and other service-related matters.
Unlike automated appointment reminders and random drug and alcohol testing notifications, Elevate allows clients and clinicians to communicate directly and respond to one another.
Message frequency varies based on client-initiated communication, clinical needs, and ongoing treatment coordination. Message and data rates may apply depending on the client's mobile carrier and service plan.
Elevate communications are separate from automated random testing notifications sent through Twilio. Clients should contact their assigned clinician directly through Elevate to request alternative testing arrangements or discuss individual treatment concerns.
Electronic communications may not be completely secure or confidential. Clients should be aware that messages may be visible to others with access to their devices. Elevate is not intended for emergency communication.
For emergencies, call 911.
Appointment Reminder Authorization through EHR
Automated appointment reminders through Oxytocin Clinic's Electronic Health Record (EHR) require separate, voluntary written authorization.
Clients must affirmatively select their preferred communication method, including SMS or email, and sign Oxytocin Clinic's Authorization for Appointment Reminders form before receiving automated appointment notifications.
No client is enrolled in the automated appointment reminder program, and no automated reminders are sent, until the clinic obtains written authorization.
The authorization form identifies the available communication methods and explains the purpose of appointment reminders and applicable communication preferences.
Clients who decline or do not provide authorization are not enrolled in the automated appointment reminder program and therefore do not need to opt out.
Clients who previously authorized appointment reminders may withdraw or modify their authorization at any time by contacting Oxytocin Clinic directly. The clinic will update their communication preferences and discontinue the affected notifications.
Consent to receive automated appointment reminders is voluntary and is not a condition of receiving treatment. Declining or revoking authorization does not excuse clients from attending scheduled appointments or fulfilling other treatment and monitoring requirements.
Authorization for EHR appointment reminders does not automatically authorize Twilio random drug and alcohol testing notifications. Each program requires its own written authorization.
Random Testing SMS Authorization through Twilio
Random drug and alcohol testing SMS notifications require separate, voluntary written authorization.
Clients must affirmatively select an initially unchecked YES option and sign Oxytocin Clinic's Authorization for Random Drug and Alcohol Testing Text Notifications form before being enrolled in the automated SMS notification program.
We do not enroll a client in the automated SMS notification program, and we do not send automated testing notifications, until we obtain written authorization.
The authorization form explains the purpose and type of messages, variable message frequency, potential message and data charges, and STOP/HELP instructions.
Clients who select NO or do not provide written authorization are not enrolled in the SMS notification program and therefore do not need to opt out. These clients must follow Oxytocin Clinic's established daily call-in procedures, Monday through Friday between 8:30 AM and 9:00 AM Mountain Time, to determine whether they have been selected for required testing.
Clients who previously authorized automated SMS notifications may revoke their consent at any time by replying STOP or contacting Oxytocin Clinic directly.
Consent to receive automated random testing notifications is voluntary and is not a condition of receiving treatment. Declining or revoking SMS authorization does not excuse clients from required drug and alcohol testing or other treatment and monitoring obligations.
Authorization for EHR appointment reminders does not automatically authorize Twilio random testing notifications, and authorization for Twilio random testing notifications does not automatically authorize EHR appointment reminders.
D. Message Frequency & Data Rates
Elevate Direct Client Communication
Elevate provides direct, two-way telephone and text messaging communication between clients and their assigned clinicians for treatment-related questions, appointment scheduling, care coordination, and other clinical needs.
Message frequency varies based on client-initiated communications, clinical needs, and ongoing treatment coordination. Unlike automated appointment reminders and random drug and alcohol testing notifications, Elevate communications do not follow a predetermined messaging schedule.
EHR Appointment Reminders
Appointment reminders are generally sent approximately 48 hours, 24 hours, and 1 hour before scheduled appointments.
Actual reminder frequency depends on the number of scheduled appointments and the client's authorized communication methods.
Twilio Random Testing Notifications
Random testing notifications are generally sent at approximately 7:00 AM Mountain Time on days when a client is selected for testing.
Message frequency varies depending on the client's treatment program and monitoring requirements, with a maximum of one testing notification per day and three testing notifications per week.
Message and Data Rates
Message and data rates may apply to SMS communications through Elevate, the Electronic Health Record (EHR), and Twilio, depending on the client's mobile carrier and service plan.
E. Opt-Out & HELP Instructions
Clients may decline, modify, or withdraw authorization for electronic communications according to the applicable communication system.
Clients who have not authorized automated appointment reminders or random drug and alcohol testing notifications are not enrolled in those messaging programs and do not need to opt out.
Elevate Direct Client Communication
Elevate provides direct, two-way telephone and text messaging communication under Oxytocin Clinic's general communication authorization.
Clients may request that telephone calls or text messages through Elevate be discontinued at any time by notifying their assigned clinician or contacting Oxytocin Clinic directly.
Upon receiving an opt-out request, Oxytocin Clinic will document the request, update the client's communication preferences, and cease the requested Elevate communications.
Opting out of Elevate communications does not automatically revoke separately authorized EHR appointment reminders or Twilio random testing notifications unless the client requests that all clinic communications cease.
Discontinuing Elevate communications does not eliminate the client's treatment, appointment, testing, court, probation, or other monitoring responsibilities.
EHR Appointment Reminders
Clients who have not provided written authorization for automated appointment reminders are not enrolled in the EHR notification program and do not need to opt out.
Clients who previously authorized appointment reminders may modify or revoke their authorization at any time by contacting Oxytocin Clinic and requesting an update to their communication preferences.
Upon receiving a request, Oxytocin Clinic will update the client's EHR communication preferences and discontinue the affected automated notifications.
Opting out of EHR appointment reminders does not automatically revoke separately authorized Twilio random testing notifications or Elevate communications unless the client requests that all clinic communications cease.
Twilio Random Testing Notifications
Clients who have not provided written authorization for automated random drug and alcohol testing notifications are not enrolled in the Twilio SMS notification program and do not need to opt out.
Clients who previously authorized random testing SMS notifications may withdraw their consent at any time.
Reply STOP to opt out of automated random testing notifications.
Reply HELP to receive automated information about contacting Oxytocin Clinic.
For nonemergency assistance, contact Oxytocin Clinic directly at (406) 314-6565.
Twilio notifications are automated and are not monitored for individual client conversations. Replying to a notification does not contact the client's counselor or constitute a request for alternative testing arrangements.
When a client opts out of Twilio notifications, the affected telephone number is blocked from further automated messages through Twilio's applicable suppression procedures. Oxytocin Clinic also maintains a separate opt-out tracking process to document and honor the client's request.
Clients who decline or revoke random testing SMS authorization must call Oxytocin Clinic every Monday through Friday between 8:30 AM and 9:00 AM Mountain Time to determine whether they have been selected for required testing.
Clients selected for required random drug or alcohol testing must report during the following collection hours:
Kalispell: Monday–Friday, 8:30 AM–4:30 PM.
Libby: Monday–Friday, 12:00 PM–7:00 PM.
If a client cannot complete testing during established collection hours, the client must contact their individual counselor that same day, before the collection period ends, to request approval for alternative testing arrangements.
Declining or revoking SMS authorization does not eliminate appointment attendance, testing, treatment, court, probation, or other monitoring requirements.
Opting out of Twilio notifications does not automatically revoke separately authorized EHR appointment reminders or Elevate communications unless the client requests that all clinic communications cease.
Opt-Out of All Clinic Communications
Clients may request that all nonessential telephone calls and text messages from Oxytocin Clinic be discontinued, regardless of the communication system used.
When a client requests that all clinic communications cease, Oxytocin Clinic will document the request, update the client's communication preferences, and discontinue applicable telephone and SMS communications through Elevate, the EHR, and Twilio.
We will honor a request to stop all clinic communications across all three systems, rather than limiting it to the system through which the request was received.
Opting out of electronic communications does not eliminate the client's responsibility to comply with treatment, appointment, random drug and alcohol testing, court, probation, or other monitoring requirements.
Clients who decline or discontinue random testing SMS notifications must follow the clinic's established daily call-in procedures.
Oxytocin Clinic may continue communications when required or otherwise permitted by applicable law, using an appropriate authorized communication method.
Message Delivery and Carrier Responsibility
Electronic message delivery depends on mobile carrier availability, network conditions, device settings, and accurate contact information.
Carriers are not liable for delayed or undelivered messages.
Oxytocin Clinic cannot guarantee the delivery or receipt of individual electronic notifications. Clients remain responsible for meeting applicable appointment, treatment, testing, and monitoring obligations, regardless of whether they receive an electronic notification.
F. Data Sharing & Disclosure
Oxytocin does not sell client personal information, mobile telephone numbers, or SMS consent information.
Oxytocin does not share SMS opt-in data, mobile numbers, or consent information with third parties or affiliates for marketing or promotional purposes.
Information necessary to provide authorized communications may be disclosed to approved service providers, including Elevate, the EHR provider, Twilio, telecommunications carriers, and other vendors involved in delivering communications, when permitted by applicable law and subject to required privacy and confidentiality safeguards.
Oxytocin maintains appropriate confidentiality protections for substance use disorder treatment information, including applicable HIPAA and 42 CFR Part 2 requirements.
Oxytocin recognizes applicable federal and state restrictions on unauthorized communications, including relevant Do Not Call and consumer communication requirements.
G. Security of Your Information
Oxytocin takes reasonable administrative, technical, and organizational measures to protect personal and communication information.
Access to communication records is restricted according to staff responsibilities and applicable confidentiality requirements.
Although reasonable safeguards are maintained, standard SMS communications may not be completely secure. Messages may be viewed by individuals who have access to the recipient's telephone, and delivery may be delayed or unsuccessful.
Oxytocin Clinic limits the information contained in electronic communications through Elevate, the Electronic Health Record (EHR), and Twilio to what is reasonably necessary for the intended communication. The clinic takes appropriate precautions to minimize unnecessary disclosure of confidential client information, including protected health information and substance use disorder treatment records, in accordance with applicable HIPAA and 42 CFR Part 2 requirements.
Automated appointment reminders and random drug and alcohol testing notifications are limited to necessary scheduling and testing information. Direct communications through Elevate may include additional treatment-related information when appropriate and authorized, subject to applicable privacy and confidentiality safeguards.
Clients are responsible for notifying Oxytocin when their contact information or communication preferences change.
H. Record-Keeping & Proof of Consent
Oxytocin maintains records supporting its authorized electronic communications, including:
-
Signed appointment reminder authorizations.
-
Signed random testing SMS authorizations.
-
Client communication preferences and consent dates.
-
Records of consent modification and revocation.
-
SMS opt-out requests and related processing records.
-
Documentation of available message transmission, delivery, and notifications.
Oxytocin maintains records in accordance with applicable treatment recordkeeping, privacy, and retention requirements, including relevant TCPA, carrier, and Campaign Registry requirements.
Oxytocin maintains separate documentation for EHR appointment reminders and Twilio random testing notifications, as appropriate to each system.
I. Changes to These SMS Terms
Oxytocin may update these SMS Terms and Conditions to reflect changes in applicable laws, communication practices, technology, service providers, or privacy and security procedures.
Material changes will be communicated through appropriate authorized channels or by posting updated Terms and Conditions on the Oxytocin website.
Changes to these Terms do not automatically expand a client's existing SMS authorization. Additional consent will be obtained when required.
J. Contact Us
If you have questions about these SMS Terms and Conditions, wish to review your communication preferences, or want to modify or revoke an authorization, please contact Oxytocin Clinic directly.
Email: info@oxytocinclinic.com
Phone: (406) 314-6565
Address: 1203 US Highway 2 West, Suite 15, Kalispell, MT 59901
5. Parent & Guardian Responsibility
If services are being provided to a minor, you certify that you are the child's parent or legal guardian and have the legal authority to consent to treatment. Unless Montana law permits otherwise or the parent or guardian authorizes it, communications regarding minors will generally be directed to the parent or legal guardian.
6. Billing & Financial Responsibility
Insurance Verification
Although Oxytocin will verify insurance benefits whenever possible, verification does not guarantee payment.
Coverage
Insurance companies determine medical necessity and covered benefits. Clients remain financially responsible for services insurance does not cover.
Prior Authorization
Certain insurance plans require prior authorization before treatment begins or continues. Delays or denials by your insurance carrier may affect coverage.
Maintaining Eligibility
Clients are responsible for maintaining active insurance coverage and notifying Oxytocin of any insurance changes.
Client Responsibility
Clients are responsible for:
-
Copayments
-
Coinsurance
-
Deductibles
-
Non-covered services
-
Court-ordered services not covered by insurance
Court-Ordered Services
Many court-ordered services, including DUI/ACT assessments, MIP assessments, educational classes, and other legal requirements, are not covered by health insurance because they are performed to satisfy a legal obligation rather than to diagnose or treat a medical condition.
The client is responsible for payment for these services unless another payment arrangement has been approved. Payment is expected at the time of enrollment in assessment services and at the time of other services rendered.
Cancellations & No Shows
Appointments not canceled within the required notice period or missed appointments may be subject to cancellation or no-show fees that are not billable to insurance.
Billing Corrections
Oxytocin reserves the right to correct billing errors and submit corrected insurance claims when appropriate.
Care Coordination
With appropriate authorization or as otherwise permitted by law, Oxytocin may coordinate care with physicians, therapists, hospitals, probation officers, attorneys, schools, or other treatment providers to support continuity of care.
7. Telehealth Services
Telehealth services are provided using secure, HIPAA-compliant technology whenever clinically appropriate.
By participating in telehealth services, you acknowledge:
-
Technical interruptions may occur.
-
Internet connectivity may affect session quality.
-
Privacy cannot be absolutely guaranteed when using electronic communication.
-
You must be physically located in a jurisdiction where your provider is legally authorized to practice.
8. Limitation of Liability
Oxytocin is not responsible for indirect, incidental, or consequential damages arising from the use of this website or electronic communication systems. Nothing contained within these Terms limits any rights or protections provided under applicable Montana or federal law.
9. Privacy & Data Protection
Oxytocin is committed to protecting your privacy and maintaining the confidentiality of your health information in accordance with HIPAA, 42 CFR Part 2 (when applicable), and applicable Montana law. We do not sell personal information.
Third-party vendors may assist with scheduling, billing, electronic health records, messaging, and other operational functions. These vendors are contractually required to safeguard your information. SMS opt-in information will never be sold or shared for marketing purposes.
10. Governing Law
These Terms & Conditions are governed by the laws of the State of Montana and applicable federal laws.
11. Changes to These Terms
Oxytocin reserves the right to update these Terms & Conditions at any time. Any revisions will take effect upon posting on this website unless otherwise required by law. Continued use of our website or services after revisions constitutes acceptance of the updated Terms & Conditions.